Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Inc.? Von Eschenbach Vows To Bring Corporate Practices To Agency

Executive Summary

FDA Commissioner nominee Andrew von Eschenbach is committed to bringing corporate business practices to the agency if confirmed

You may also be interested in...



FDA Gets Operations Chief From CMS As Woodcock Moves To Medical Post

FDA Commissioner Andrew von Eschenbach's first reorganization of the agency involves focusing on its "business" operations

FDA Gets Operations Chief From CMS As Woodcock Moves To Medical Post

FDA Commissioner Andrew von Eschenbach's first reorganization of the agency involves focusing on its "business" operations

FDA Morale Improvement Will Be A Priority, Von Eschenbach Testifies

Acting Commissioner Andrew von Eschenbach stressed his commitment to improving agency morale during his confirmation hearing

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047061

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel